Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Rafael Fonseca, including the following topics:

Recent updates from ASH 2024 on the up-front use of anti-CD38 monoclonal antibodies for multiple myeloma (MM) (0:00)

Updated data with belantamab mafodotin for the management of MM (12:39)

Updated findings with chimeric antigen receptor T cell therapy for the management of MM (17:52)

ASH 2024 updates with other novel agents and strategies for the management of MM (21:32)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.